FFAR2 and inflammatory bowel disease: A decrease in the concentration of SCFAs such as butyrate, propionate and acetate reduces the number of Treg in the gut upsetting the Th17/Treg balance, and the level of mRNA FFAR2 changes with the development of experimental inflammatory bowel disease (IBD) (21).